IntegraGen has announced today its financial results for the first half of semester 2018 with the accounts having been examined by the company’s Board of Directors on September 20, 2018.

  • Sales revenue: 3.7 M€, +17% vs. H1 2017
  • Significant growth in genomics services
  • Operating profit: -0.5 M€, + 57% vs. H1 2017

Click here to view press release